Skip to content
Screener

Viemed Healthcare, Inc. VMD Q2 2025 earnings

Reported August 6, 2025 · After market close

Revenue$63.1MMiss by $444.0K
EPS$0.08Miss by $0.01
Revenue estimate$63.5M
EPS estimate$0.09

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$80.8M
EPS estimate$0.12

Financials

Q2 2025

Income statement

See full
Revenue$63.1M+14.7%
Gross profit$36.7M+11.7%
Operating income$5.1M+40.9%
Net income$3.2M+115%
EPS (diluted)$0.08+100%

Balance sheet

See full
Cash & equivalents$20.0M+127%
Total debt$6.9M-44.7%
Total equity$139.7M+17.1%
Total assets$184.6M+12.6%

Cash flow

See full
Operating cash flow$12.3M+20.3%
CapEx$8.1M-9.0%
Free cash flow$4.1M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$273.9M+8.0%
Enterprise value$260.77M+1.4%
P/E19.6×-7.2×
P/S1.1×-0.1×

Profitability

See full
Gross margin58.3%-2.6pp
Operating margin8.7%+1.3pp
Net margin5.8%+1.2pp

Returns & leverage

See full
Return on equity10.8%+2.3pp
Debt / equity0×-0.1×
Current ratio1.5×+0.1×

Segments

By product

See full
Equipment and supply sales$9.5M+29.0%
Service revenues$5.9M+19.7%

FAQ

When did Viemed Healthcare, Inc. report Q2 2025 earnings?
Viemed Healthcare, Inc. (VMD) reported Q2 2025 earnings on August 6, 2025 after market close.
What were Viemed Healthcare, Inc.'s Q2 2025 revenue and EPS?
Viemed Healthcare, Inc. reported revenue of $63.1M and eps of $0.08 for Q2 2025.
Did Viemed Healthcare, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $63.5M by $444.0K. EPS missed the consensus estimate of $0.09 by $0.01.
How did Viemed Healthcare, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.7% from $55.0M a year earlier and eps grew 100.0% from $0.04.
Where can I find Viemed Healthcare, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001729149-25-000118) and the 10-Q periodic report (0001729149-25-000119) directly on SEC EDGAR. The filing index links above go to sec.gov.